BSX · News · 20260809N
Capital Return Program
BOSTON SCIENTIFIC CORP · 2026-08-09 · Importance 64 · Surprise 42 · In source text
Boston Scientific authorized a $5 billion share-repurchase program following its second-quarter 2026 results. The authorization was cited alongside quarterly revenue of $5.44 billion and adjusted EPS of $0.86. The digest does not specify the program’s expiration date, execution timing, or repurchase amount completed to date.
Key facts
- BOSTON SCIENTIFIC CORP's board authorized a $5 billion share-repurchase program. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | — | BOSTON SCIENTIFIC CORP's board authorized a $5 billion share-repurchase program. |